Volta Labs Expands Callisto Platform With Automated WGS Library Prep Apps
Callisto system now supports seven validated DNA library preparation workflows across multiple sequencing platforms and chemistries.
Callisto system now supports seven validated DNA library preparation workflows across multiple sequencing platforms and chemistries.
Researchers identify critical flaws in Oxford Nanopore devices that could expose or alter genetic data without detection.
Researchers are developing a large-scale olfactory dataset to train artificial intelligence, potentially unlocking smell as a powerful tool for early disease detection.
The integration is designed to bridge specimen grossing with digital pathology workflows for improved diagnostic accuracy and efficiency.
Market research projects 17.15% compound annual growth rate driven by AI integration and cloud-based platforms.
The ethyl alcohol assay categorization enables moderate complexity laboratories to expand drug screening capabilities on the Abbott analyzer platform.
New plate-based multiplexing can profile up to 384 samples and 100 million cells per week.Â
With 70% of medical decisions depending on blood testing, experts highlight the toll of missed testing and the promise of alternative collection methods.
Market growth driven by expanding clinical applications and regulatory innovation, with kits and reagents dominating product segments.
The extraction-free library preparation technology is designed to deliver full transcriptome coverage for drug screening and toxicology studies.
New clearances expand MALDI-TOF platform capabilities with improved software, faster sample prep, and broader species coverage.
The collaboration will focus on creating a cortisol biosensor for stress and metabolic health testing using luminescent biosensors and AI-guided interpretation.
The Seattle biotech company receives a $750,000 Gates Foundation grant to develop a rapid diagnostic using novel protein binders and a luciferase system.
The sharp increase in fentanyl in random drug checks suggests more workers are using the opioid after they have passed pre-employment screens.